Dr. Tyndall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7440 S 91st St
Lincoln, NE 68526Phone+1 402-489-6555Fax+1 402-328-3770
Education & Training
- Henry Ford Health/Henry Ford HospitalFellowship, Vascular Surgery - Independent, 1992 - 1994
- Creighton University School of Medicine (Omaha)Residency, Surgery, 1986 - 1992
- Creighton University School of MedicineClass of 1986
Certifications & Licensure
- NE State Medical License 1991 - 2026
- KS State Medical License 1997 - 2019
- IA State Medical License 1986 - 1997
- MI State Medical License 1993 - 1997
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Clinical Trials
- Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 3 citationsProper technical procedures improved outcomes in a retrospective analysis of EVAS FORWARD IDE trial 3-year results.Jeffrey P. Carpenter, John S. Lane, Jose Trani, Sajjad Hussain, Christopher Healey
Journal of Vascular Surgery. 2020-02-05 - 30 citationsRefinement of anatomic indications for the Nellix System for endovascular aneurysm sealing based on 2-year outcomes from the EVAS FORWARD IDE trial.Jeffrey P. Carpenter, John S. Lane, Jose Trani, Sajjad Hussain, Christopher Healey
Journal of Vascular Surgery. 2018-09-01 - 8 citationsNeuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines.Divya Pankajakshan, Guanghong Jia, Iraklis I. Pipinos, Steve H. Tyndall, Devendra K. Agrawal
Experimental and Molecular Pathology. 2011-06-01
Authored Content
- Refinement of Anatomic Indications for the Nellix System for Endovascular Aneurysm Sealing Based on 2-Year Outcomes from the EVAS FORWARD IDE TrialMarch 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: